Posted on January 15, 2021 by Aaron Warwick
Protech Home Medical (PTQQF or PTQ.V), a provider of in-home monitoring equipment, supplies, and services, on Wednesday announced they had submitted an application to be listed on the US NASDAQ. I alerted the Breakout Investor community to this possible catalyst on December 3, noting: “The company has been progressing towards meeting the requirements to list on the NYSE/Nasdaq, and they believe they will be listed in 1H 2021, likely on the earlier side of the 1H. I wouldn’t be surprised to see an announcement yet this year, or early next.”
One important note from PTQQF’s press release: “The Company intends to satisfy all of the applicable listing criteria.” Based on my research, I believe that some of these criteria will lead to PTQQF “cleaning up” some of its confusing capital structure, a move that will not necessarily be an immediate catalyst, but one that will help remove a hurdle for future potential investors, and one that will, over time, lead to PTQQF obtaining a valuation multiple comparable to its peers (which in itself could lead to a near doubling of the current share price).
I cover all of these details and more in my most recent Seeking Alpha article on the company, and will continue to periodically update the Breakout Investors community here.
Disclosure: I am long PTQQF and may buy or sell shares at any time.